A case of branch retinal artery occlusion following orbital cavernous hemangioma excision

Eur J Ophthalmol. 2014 Nov-Dec;24(6):972-5. doi: 10.5301/ejo.5000501. Epub 2014 Jun 12.

Abstract

Purpose: To report the first case of branch retinal artery occlusion (BRAO) following surgical excision of orbital cavernous hemangioma.

Methods: A 34-year-old man was referred to our department with an orbital cavernous hemangioma compressing the optic nerve, the medial rectus muscle, and the eyeball, and resulting in a hyperemic optic disc, vascular tortuosity, and pronounced choroidal folds at fundus biomicroscopy. The patient underwent transconjunctival inferior orbitotomy and the lesion was excised entirely without intraoperative complications.

Results: On the second postoperative day, best-corrected visual acuity (BCVA) decreased from 2/10 to counting fingers and fundus examination showed occlusion of the inferotemporal branch retinal artery. Fluorescein angiography and spectral-domain optical coherence tomography (SD-OCT) confirmed the diagnosis. One month of corticosteroid therapy and anticoagulation therapy were prescribed. The patient was followed up for 6 months; SD-OCT showed resolution of the retinal thickening and the retinoschisis but a new hyporeflective space in the outer retina at the fovea had appeared at 6 months follow-up. The patient's BCVA improved to 9/10 after 6 months but an absolute superior visual field defect was still present at the end of the follow-up.

Conclusions: We describe the first reported case of BRAO following orbital cavernous hemangioma excision with significant improvement of the BCVA at 6-month follow-up. The SD-OCT could be a useful tool to monitor morphologic changes of the area corresponding to the retinal ischemia.

Publication types

  • Case Reports

MeSH terms

  • Administration, Oral
  • Adult
  • Drug Therapy, Combination
  • Enoxaparin / therapeutic use
  • Fibrinolytic Agents / therapeutic use
  • Fluorescein Angiography
  • Fundus Oculi
  • Glucocorticoids / therapeutic use
  • Hemangioma, Cavernous / surgery*
  • Humans
  • Injections, Subcutaneous
  • Magnetic Resonance Imaging
  • Male
  • Ophthalmologic Surgical Procedures / adverse effects*
  • Orbital Neoplasms / surgery*
  • Prednisolone / therapeutic use
  • Retinal Artery Occlusion / diagnosis
  • Retinal Artery Occlusion / drug therapy
  • Retinal Artery Occlusion / etiology*
  • Retinoschisis / diagnosis
  • Retinoschisis / drug therapy
  • Retinoschisis / etiology
  • Tomography, Optical Coherence / methods
  • Visual Acuity / physiology

Substances

  • Enoxaparin
  • Fibrinolytic Agents
  • Glucocorticoids
  • Prednisolone